In vivo and in vitro measurement of CYP2C19 activity

被引：12

作者：

Wedlund, PJ ^{[1
]}

Wilkinson, GR ^{[1
]}

机构：

[1] VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232

来源：

CYTOCHROME P450, PT B | 1996年 / 272卷

关键词：

D O I：

10.1016/S0076-6879(96)72013-X

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：105 / 114

页数：10

共 21 条

[1] POLYMORPHIC HYDROXYLATION OF S-MEPHENYTOIN AND OMEPRAZOLE METABOLISM IN CAUCASIAN AND CHINESE SUBJECTS
ANDERSSON, T
REGARDH, CG
LOU, YC
ZHANG, Y
DAHL, ML
BERTILSSON, L
[J]. PHARMACOGENETICS, 1992, 2 (01): : 25 - 31
[2] ARNS PA, 1990, PHARMACOLOGIST, V32, P140
[3] THE HYDROXYLATION OF OMEPRAZOLE CORRELATES WITH S-MEPHENYTOIN METABOLISM - A POPULATION STUDY
BALIAN, JD
SUKHOVA, N
HARRIS, JW
HEWETT, J
PICKLE, L
GOLDSTEIN, JA
WOOSLEY, RL
FLOCKHART, DA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (06) : 662 - 669
[4] EXPRESSION OF A HUMAN-LIVER CYTOCHROME-P-450 PROTEIN WITH TOLBUTAMIDE HYDROXYLASE-ACTIVITY IN SACCHAROMYCES-CEREVISIAE
BRIAN, WR
SRIVASTAVA, PK
UMBENHAUER, DR
LLOYD, RS
GUENGERICH, FP
[J]. BIOCHEMISTRY, 1989, 28 (12) : 4993 - 4999
[5] Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: Comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype
Chang, M
Dahl, ML
Tybring, G
Gotharson, E
Bertilsson, L
[J]. PHARMACOGENETICS, 1995, 5 (06): : 358 - 363
[6] INTERPHENOTYPE DIFFERENCES IN DISPOSITION AND EFFECT ON GASTRIN-LEVELS OF OMEPRAZOLE - SUITABILITY OF OMEPRAZOLE AS A PROBE FOR CYP2C19
CHANG, M
TYBRING, G
DAHL, ML
GOTHARSON, E
SAGAR, M
SEENSALU, R
BERTILSSON, L
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (05) : 511 - 518
[7] EVIDENCE THAT CYP2C19 IS THE MAJOR (S)-MEPHENYTOIN 4'-HYDROXYLASE IN HUMANS
GOLDSTEIN, JA
FALETTO, MB
ROMKESSPARKS, M
SULLIVAN, T
KITAREEWAN, S
RAUCY, JL
LASKER, JM
GHANAYEM, BI
[J]. BIOCHEMISTRY, 1994, 33 (07) : 1743 - 1752
[8] GOLDSTEIN JA, 1996, METHODS ENZYMOL, V272, pCH23
[9] POLYMORPHIC METABOLISM OF MEPHENYTOIN IN MAN - PHARMACOKINETIC INTERACTION WITH A CO-REGULATED SUBSTRATE, MEPHOBARBITAL
JACQZ, E
HALL, SD
BRANCH, RA
WILKINSON, GR
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) : 646 - 653
[10] PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN
KUPFER, A
PREISIG, R
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) : 753 - 759

← 1 2 3 →